Clinical Trials on Secondary Hypogonadism in Australia
Total 61 results
-
Acrux DDS Pty LtdCompleted
-
Acrux DDS Pty LtdCompleted
-
Acrux DDS Pty LtdCompleted
-
Medical University of ViennaFerring Arzneimittel GmbHRecruitingHypogonadism, Hypogonadotropic | AMH | Follicle CystAustria
-
Medical University of GrazCompleted
-
Johannes Kepler University of LinzRecruitingAphakia | Secondary Cataract Surgery | Complicated Cataract SurgeryAustria
-
Eli Lilly and CompanyCompletedHypogonadismUnited States, Australia, France, Germany, Sweden, United Kingdom
-
Innate ImmunotherapeuticsSyneos HealthCompletedSecondary Progressive Multiple SclerosisNew Zealand, Australia
-
University of AdelaideUniversity of South AustraliaUnknown
-
Austin HealthCompleted
-
BayerCompletedHypogonadism | MaleGermany, Indonesia, Korea, Republic of, Malaysia, Saudi Arabia, Singapore, Spain, Thailand, Philippines, Taiwan, Australia, Austria, Bulgaria, Colombia, Czech Republic, Estonia, Hong Kong, Italy, Jordan, Kazakhstan, Latvia, Lebanon, Lithuani... and more
-
KAI PharmaceuticalsNucleus Network LtdCompletedHyperparathyroidism, SecondaryAustralia
-
KAI PharmaceuticalsCompletedHyperparathyroidism, SecondaryUnited States, Australia
-
Medical University of GrazActive, not recruitingSecondary Sclerosing CholangitisAustria
-
Alexandra Kautzky-WillerBayerRecruitingFatty Liver | Hypogonadism, Male | Overweight/Obesity | Prediabetes/Type2 Diabetes MellitusAustria
-
Novartis PharmaceuticalsCompletedMayzent (Siponimod) Onboarding of Secondary Progressive Multiple Sclerosis (SPMS) Patients With MSGoSecondary Progressive Multiple SclerosisAustralia
-
Medical University of GrazRecruitingSecondary Sclerosis Cholangitis in Critically Ill PatientsAustria
-
Ludwig Boltzmann Institute for Digital Health and...REHA Zentrum Salzburg; Reha-Klinik MontafonRecruitingCardiovascular Diseases | Cardiac Rehabilitation | Secondary PreventionAustria
-
Antisoma ResearchUnknownSecondary Acute Myeloid Leukemia (Secondary AML, sAML)Korea, Republic of, United States, Spain, United Kingdom, Australia, Austria, Taiwan, Israel, Italy, Belgium, Germany, France, Romania, Estonia, Canada, Ukraine, Ecuador, Hungary, Poland, Chile, Argentina, Czech Republic, Russian Federation
-
AbbVie (prior sponsor, Abbott)Assign Data Management and Biostatistics GmbHCompletedSecondary Hyperparathyroidism | Chronic Kidney Disease Stage V | Cardiac MorbidityAustria
-
Medical University of GrazCompleted
-
Rainer OberbauerAmgenCompletedSecondary Hyperparathyroidism | Left Ventricular Hypertrophy | Chronic Kidney Disease Requiring Chronic DialysisAustria
-
Novartis PharmaceuticalsCompletedSubfoveal Choroidal Neovascularization CNV Secondary to Wet Age-related Macular Degeneration AMDAustralia
-
Electra Therapeutics Inc.RecruitingSecondary Hemophagocytic Lymphohistiocytosis (sHLH)Netherlands, United States, Spain, Austria, United Kingdom, Italy
-
Hoffmann-La RocheRecruitingChoroidal Neovascularization Secondary to Pathologic MyopiaKorea, Republic of, China, Australia, Poland, Germany, Taiwan, Hong Kong
-
Medical University of ViennaCompletedSecondary Hyperparathyroidism | CKD-MBD - Chronic Kidney Disease Mineral and Bone Disorder | Kidney ReplacementAustria
-
The Canadian Blood and Marrow Transplant GroupNational Cancer Institute (NCI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Graft Versus Host Disease | Secondary MyelofibrosisAustralia, Canada, United States, New Zealand, Saudi Arabia
-
AmgenTerminatedHyperparathyroidism | Chronic Kidney Disease | Secondary Hyperparathyroidism | Hyperparathyroidism, Secondary | Kidney DiseaseUnited States, Belgium, Hungary, Spain, Australia, Germany, Poland, Mexico, Russian Federation, Slovakia
-
Boehringer IngelheimCompletedVenous Thromboembolism | Secondary PreventionUnited States, Norway, Canada, Belgium, Thailand, Italy, Germany, Turkey, Austria, Hungary, Czechia, Taiwan, Israel, Brazil, Denmark, France, Lithuania, Mexico, Russian Federation, Sweden, Switzerland, Ukraine
-
Medical University InnsbruckBarmherzige Brüder Vienna; Tiroler Landeskrankenanstalten GmbH (TILAK); Tiroler... and other collaboratorsCompletedStroke | Ischemic Attack, Transient | Cost-Benefit Analysis | Secondary Prevention | Disease ManagementAustria
-
NovartisCompletedSubfoveal Choroidal Neovascularization (CNV) | Secondary to Age-related Macular Degeneration (AMD)Germany, Belgium, Spain, Netherlands, United Kingdom, Hungary, Turkey, Israel, Portugal, Australia
-
AmgenCompletedChronic Kidney Disease | Secondary HyperparathyroidismUnited States, Italy, Belgium, Denmark, Switzerland, Canada, Turkey, Spain, Austria, Germany, Hungary, Greece, France, Poland, Russian Federation, Czechia, Latvia, Lithuania, New Zealand, Portugal, Sweden, Estonia
-
Aesculap AGRaylytic GmbHRecruitingKnee Osteoarthritis | Osteonecrosis | Knee Arthritis | Instability, Joint | Rheumatoid Arthritis of Knee | Deformity Knee | Primary Osteoarthritis of Knee Nos | Secondary Osteoarthritis of Knee NosAustralia, Germany
-
AbbVie (prior sponsor, Abbott)CompletedSecondary Hyperparathyroidism | Kidney InsufficiencyAustria, Germany
-
Medical University of ViennaUnknownVitamin D Deficiency | Kidney Transplantation | Renal OsteodystrophyAustria
-
Boehringer IngelheimCompletedStroke | Secondary PreventionKorea, Republic of, United States, Spain, Canada, Germany, Taiwan, Belgium, Australia, Hong Kong, India, Singapore, Thailand, Greece, Italy, Japan, China, Turkey, Russian Federation, Serbia, Switzerland, Israel, South Africa, Malaysia, Fran... and more
-
Apellis Pharmaceuticals, Inc.Active, not recruitingGeographic Atrophy Secondary to Age-related Macular DegenerationUnited States, Netherlands, France, Israel, Germany, United Kingdom, Canada, Czechia, Australia, Spain, Italy, Argentina, Brazil, New Zealand, Poland
-
AmgenCompletedHyperparathyroidism, SecondaryUnited States, Belgium, Italy, Switzerland, Canada, Turkey, Spain, Australia, Austria, Israel, Czechia, Hungary, Poland, France, Russian Federation, Germany, Denmark, Greece, Latvia, Lithuania, Netherlands, New Zealand, Portugal, Sweden
-
SanofiActive, not recruitingSecondary Progressive Multiple SclerosisUnited States, Argentina, Belgium, Canada, Czechia, France, Germany, Greece, India, Israel, Netherlands, Norway, Portugal, Turkey, United Kingdom, Japan, Austria, Bulgaria, China, Denmark, Finland, Italy, Lithuania, Poland, Romania, Russian... and more
-
AmgenCompletedHyperparathyroidism, SecondaryUnited States, Belgium, Canada, France, Australia, Israel, Czechia, Hungary, Netherlands, Spain, Poland, Russian Federation, Italy, Sweden, Germany
-
AmgenCompletedHyperparathyroidism, SecondaryUnited States, Belgium, Italy, United Kingdom, Canada, Germany, Spain, Australia, Austria, Israel, Czechia, Hungary, Netherlands, Poland, France, Russian Federation, Sweden
-
AmgenCompletedHyperparathyroidism, SecondaryUnited States, Belgium, Italy, United Kingdom, Canada, Germany, Spain, Austria, Czechia, Hungary, France, Israel, Poland, Australia, Russian Federation
-
BayerRegeneron PharmaceuticalsRecruitingMacular Edema Secondary to Retinal Vein OcclusionJapan, Korea, Republic of, China, Israel, Lithuania, United States, Italy, Spain, Hungary, Portugal, Serbia, Poland, United Kingdom, Thailand, Czechia, Austria, Germany, Turkey, Australia, Bulgaria, Estonia, France, Georgia, Latvia, Mal... and more
-
Novartis PharmaceuticalsCompletedAcute Myelogenous Leukemia | Refractory LeukemiaBelgium, Korea, Republic of, Turkey, Germany, Australia, France, Switzerland, United Kingdom, Spain, Italy, Peru, United States
-
OctapharmaCompletedPrimary and Secondary Immunodeficiency and Other Conditions Requiring Regular Administration of Octagam 5% or 10% IVIGCanada, Austria, France, Spain, United Kingdom
-
Novartis PharmaceuticalsCompletedSecondary Progressive Multiple SclerosisChina, Germany, United States, Romania, Italy, Austria, Belgium, Czechia, Spain, Australia, Canada, France, Israel, Switzerland, Japan, Bulgaria, Netherlands, United Kingdom, Estonia, Latvia, Lithuania, Russian Federation, Turkey, Slo... and more
-
UCB Pharma GmbHCompletedFocal Epilepsy With and Without Secondary GeneralizationGermany, Austria
-
SanofiRecruitingMultiple SclerosisUnited States, Canada, Australia
-
Boston Scientific CorporationCompletedPrimary Prevention of Sudden Cardiac Arrest | Secondary Prevention of Sudden Cardiac ArrestUnited States, Canada, Australia
-
Atara BiotherapeuticsTerminatedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States, Australia, Canada